Day: February 4, 2026

This is the third program that successfully combines Entera’s oral peptide N-Tab® platform with OPKO’s advanced protein chemistry capabilities The companies have accelerated this program and aim to file an investigational new drug (IND) application in late 2026 Injectable and oral oxyntomodulin (dual GLP-1/glucagon analog) for metabolic and fibrotic disorders advancing with initial Phase 1 data from injectable oxyntomodulin (OXM) expected in late 2026; oral OXM to enter clinic thereafter Industry veteran Steve Rubin joins Entera’s board MIAMI and TEL AVIV, Feb. 04, 2026 (GLOBE NEWSWIRE) — OPKO Health, Inc.  (NASDAQ: OPK), through its wholly owned subsidiary, OPKO Biologics (OPKO), and Entera Bio Ltd. (NASDAQ: ENTX) (Entera or the Company), a leader in the development of oral peptide and protein replacement therapies, today announced...

Zeta Network Group (NASDAQ : ZNB) Evaluates Real-World Asset Tokenisation for Institutional Treasury StrategyNew York, Feb. 04, 2026 (GLOBE NEWSWIRE) — 4 February, 2026:  Zeta Network Group (Nasdaq: ZNB) today outlined its strategic focus on real-world asset (RWA) tokenisation as a potential extension of its institutional digital-asset treasury approach, reflecting its assessment of emerging developments in balance-sheet and capital-management practices. As digital assets gain wider acceptance among public companies, Zeta observes that treasury strategies are evolving beyond simple asset holding toward greater diversification, capital efficiency, and governance-aligned deployment. Real-world asset tokenisation may offer a way to represent familiar financial instruments on-chain in formats aligned with institutional risk, compliance,...

Annual Report for 2025for ROCKWOOL A/SRelease no. 08 – 2026to Nasdaq Copenhagen 4 February 2026 Robust 2025 performance in a volatile and challenged market HighlightsOn 13 January 2026, ROCKWOOL effectively lost control of the Russian business. Consequently, a loss of 392 MEUR from value adjustment related to the Russian business was recognised in 2025. Revenue in 2025 reached 3,877 MEUR, an increase of 1.1 percent in local currencies. 2024 acquisitions accounted for 1.2 percent. In Q4 2025, revenue reached 967 MEUR, an increase of 0.8 percent in local currencies. EBITDA in 2025 was 864 MEUR, with a 22.3 percent EBITDA margin, down 2.1 percentage points to 2024. EBITDA in Q4 2025 was 199 MEUR, with a 20.5 percent EBITDA margin, down 3.2 percentage points. Earnings declined due to the production-related incident in Flums, Switzerland,...

The Company Remains Open to Constructive DialogReiterates Focus on Execution and Governance Changes for Continued Evolution to a Dynamic SaaS BusinessCALGARY, Alberta, Feb. 04, 2026 (GLOBE NEWSWIRE) — Sylogist Ltd. (TSX: SYZ) (“Sylogist” or the “Company”), a leading public sector SaaS company, today announced that it has received a shareholder meeting requisition notice pursuant to section 142 of the Business Corporations Act (Alberta) dated January 29, 2026 from OneMove Capital LLC (the “dissident”). The Company is reviewing the requisition with the assistance of its professional advisors and will respond appropriately in due course. In the meantime, there is no need for shareholders to take any action. The Company Remains Open to Constructive Dialog with Shareholders The dissident purports to hold approximately 9.09% of...

LIMERICK, Ireland, Feb. 04, 2026 (GLOBE NEWSWIRE) — kneat.com, inc. (TSX: KSI, OTCQX: KSIOF) (“Kneat” or the “Company”), a leader in digitizing and automating validation and quality processes, announced today that the Company will release its financial results for the quarter ended December 31, 2025, after TSX market close on February 25, 2026. Eddie Ryan, Chief Executive Officer and Dave O’Reilly, Chief Financial Officer, will host a conference call and Q&A for sell side analysts via webcast on February 26 at 09:00 ET (14:00 GMT). Interested parties can register for the live webcast via the following link: Register Here Kneat’s fourth-quarter and full-year financial results will be available from the Financial Information section of the Investors page on the Kneat Solutions website, at: https://kneat.com/investors/  About...

RICHMOND, VA, Feb. 04, 2026 (GLOBE NEWSWIRE) — CarMax, Inc. (NYSE: KMX), the nation’s largest retailer of used cars, has been recognized by TIME Magazine as one of America’s Most Iconic Companies. The project, created in partnership with Statista Inc., marks the 250th anniversary of the United States and honors 250 companies that have become enduring symbols of American business, culture, and identity. This positive recognition reaffirms CarMax’s decades-long dedication to providing a transparent and customer-centric experience. CarMax is honored to be included among other automotive brands, including Ford Motor Company, General Motors, and Tesla. CarMax’s commitment to innovation and iconic customer experiences has helped make the company the nation’s largest retailer of used cars. As the original disruptor of the automotive...

WASHINGTON, Feb. 04, 2026 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of Jane Wanklyn as a Senior Managing Director in the Business Transformation practice within the firm’s Corporate Finance & Restructuring segment. Ms. Wanklyn, who is based in Chicago, joins with more than two decades of experience specializing in large-scale procurement, supply chain and organizational transformations. She has worked with clients in the automotive, aerospace and defense, consumer products, industrials and other sectors, and is well-known for her expertise in cost reduction, value creation, organizational design and digital procurement strategy. In her role at FTI Consulting, Ms. Wanklyn will focus on driving sustainable results for clients through large-scale cost and organizational transformations....

COLUMBUS, Ohio, Feb. 04, 2026 (GLOBE NEWSWIRE) — Bread Financial® Holdings, Inc. (NYSE: BFH), a tech-forward financial services company that provides simple, personalized payment, lending, and saving solutions, today announced the company’s participation in the UBS Financial Services Conference on Wednesday, February 11. Bread Financial EVP and Chief Financial Officer Perry Beberman will participate in a fireside chat. The fireside chat will take place at 12:10 p.m. ET and will be broadcast live here. The fireside chat can also be accessed through Bread Financial’s investor relations website. A replay of the webcast will be available for 90 days following the event. About Bread Financial®Bread Financial® (NYSE: BFH) is a tech-forward financial services company that provides simple, personalized payment, lending and saving solutions...

Battle Born® DualFlow Power Pack recognized for reducing fuel waste and CO2 emissions while improving fleet efficiency and driver comfortRENO, Nev., Feb. 04, 2026 (GLOBE NEWSWIRE) — Dragonfly Energy Holdings Corp. (Nasdaq: DFLI) (“Dragonfly Energy” or the “Company”), an industry leader in energy storage and battery technology and maker of Battle Born Batteries®, won both the Sustainable Innovation Award and the Sustainable Product Award at the 2026 SEAL (Sustainability, Environmental Achievement, Leadership) Business Sustainability Awards. The honors recognize Dragonfly Energy’s Battle Born® DualFlow Power Pack, a lithium power solution designed to significantly reduce diesel engine idling in long-haul trucking, one of the industry’s most persistent sources of fuel waste and carbon emissions. In real-world fleet use, Dragonfly...

New capabilities to be launched on March 25 Unique technology bolsters BullFrog AI’s end-to-end AI intelligence workflow with a scenario-based decision engine Advances current AI decision tools by clearly defining clinical trial strategies and building diversified, risk-balanced R&D portfoliosGAITHERSBURG, Md., Feb. 04, 2026 (GLOBE NEWSWIRE) — BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) (“BullFrog AI” or the “Company”), a technology company using artificial intelligence (“AI”) and machine learning to turn complex biomedical data into actionable insights, announces the coming launch of a new scenario-based decision engine for pharmaceutical portfolio strategy and clinical trial design. The new AI capability advances the Company’s end-to-end intelligence workflow by adding a strategic decision...